Pfizer is set to relocate its headquarters to The Spiral

By Catherine Sturman
Biopharmaceutical giant Pfizer has signed a 20-year lease for The Spiral, an office skyscraper being built by Tishman Speyer, at Hudson Yards of Manhatt...

Biopharmaceutical giant Pfizer has signed a 20-year lease for The Spiral, an office skyscraper being built by Tishman Speyer, at Hudson Yards of Manhattan. The company will occupy 15 floors and will begin moving colleagues there in 2022.

“Pfizer’s history in New York City began in 1849, and we are proud to continue our commitment to the city with our move to The Spiral in Manhattan,” said Albert Bourla, Pfizer Chief Operating Officer. “In relocating our headquarters, we sought to provide our colleagues a modern, state-of-the-art headquarters that would foster greater collaboration and innovation in a vibrant neighbourhood in Manhattan.”

In addition, Pfizer made a contribution of $500mn to the Hudson Guild, a multi-service community agency serving those who live, work, or go to school in Chelsea, with a focus on those in need. Pfizer’s donation being disbursed over five years will support Hudson Guild’s ongoing programs and services to low-income residents of Chelsea and the West Side, including free and low-income pre-k, afterschool programs, college prep, career services to young adults, mental health counselling recreational activities and meals for older adults. This is on top of an arts and theatre program.

See also

Ken Jockers, Hudson Guild Executive Director, stated, “The whole community benefits when companies like Pfizer step up with meaningful support. It strengthens our ability to strategically meet the needs of our constituents.”

Pfizer is currently in the process of selling its headquarters property on East 42nd Street, which it has occupied since 1961.

Construction will begin on The Spiral in June this year. Costing $3.7bn, the building has been designed by Bjarke Ingels and will span 1,031ft. featuring a cascading series of landscaped terraces and hanging gardens, the terraces will ascend, one per floor, in a spiralling motion to create a unique, continuous green pathway that wraps around the façade of the tower and supplies occupants with readily accessible outdoor space, according to a recent press release.

The six-story base of the building will also include a lobby with ceiling heights of up to 28ft and main entrances on Hudson Boulevard East and 10th Avenue.  The base also will include approximately 25,000 square feet of first-class retail. 

 

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare